{"url_path":"/sec/bngo/8-k/2026-06-24/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-24","source_url":"https://www.sec.gov/Archives/edgar/data/1411690/0001411690-26-000040-index.html","accession_number":"0001411690-26-000040","cik":"0001411690","ticker":"BNGO","issuer_name":"Bionano Genomics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1411690/0001411690-26-000040-index.html","primary_entity_key":"0001411690","primary_entity_name":"Bionano Genomics, Inc."},"word_count":86,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\nExhibit No.\n\n \n\nDescription\n\n99.1\n\n \n\n[Press Release, dated June 24, 2026.](bngo-ex99_1.htm)\n\n104\n\n \n\nInline XBRL for the cover page of this Current Report on Form 8-K\n\n \n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\nBionano Genomics, Inc.\n\n \n\n \n\n \n\n \n\nDate: June 24, 2026\n\nBy:\n\n/s/ Albert A. Luderer, Ph.D.\n\n \n\n \n\nAlbert A. Luderer, Ph.D.\n\n \n\n \n\nInterim Chief Executive Officer"}